News
- Author:
- Susan London
Publish date: October 16, 2018
SAN DIEGO – Among patients with left main coronary artery disease, a benefit of CABG over PCI with drug-eluting s...
News
- Author:
- Susan London
Publish date: October 3, 2018
A nested case-control study of nearly 5,000 individuals and a subsequent meta-analysis found that obese patients have elevated risks of clear cell ...
News
- Author:
- Susan London
Publish date: October 2, 2018
In the single-arm, phase 2 trial, more than half of renal cell carcinomas responded to pazopanib, with a median reduction in tumor size of 40.5%.
News
- Author:
- Susan London
Publish date: September 29, 2018
San Diego – The gain in 6-minute walk distance was about four times greater with pulmonary artery denervation tha...
News
- Author:
- Susan London
Publish date: September 25, 2018
SAN DIEGO – Preparatory rotational atherectomy’s early edge over modified balloon may not last.
News
- Author:
- Susan London
Publish date: September 24, 2018
SAN DIEGO – About one in eight patients have severe PPM after undergoing TAVR, according to the largest study to date of this population.
News
- Author:
- Susan London
Publish date: September 23, 2018
SAN DIEGO – Positive results of the LEADERS FREE II trial in patients at high bleeding risk undergoing PCI bode w...
News
- Author:
- Susan London
Publish date: August 24, 2018
PRCC subtypes 1 and 2 have differing histologic features and immunohistochemical profiles, but subtype does not independently predict overall survi...
News
- Author:
- Susan London
Publish date: August 16, 2018
Rituximab maintenance therapy prolonged progression-free survival. Risk of grade 3 or 4 neutropenia was increased, but risk of infection was not.
News
- Author:
- Susan London
Publish date: August 14, 2018
Patients undergoing autologous hematopoietic stem cell transplant (auto-HSCT) for lymphoma or myeloma have an increased risk of acute myeloid leuke...
News
- Author:
- Susan London
Publish date: August 10, 2018
For patients with lymphoma or plasma cell myeloma, autologous hematopoietic cell transplantation was linked to marked increases in the risk of AML ...
Article
- Author:
- Susan London
Publish date: August 10, 2018
Among patients with advanced NSCLC treated in community oncology practices, broad-based genomic sequencing seldom exclusively informed the treatmen...
News
- Author:
- Susan London
Publish date: July 19, 2018
CHICAGO – Biosimilars for three widely used oncology drugs showed efficacy and safety similar to those of the reference products in lung cancer and...
News
- Author:
- Susan London
Publish date: July 9, 2018
CHICAGO – In a 20-country neoadjuvant trial, findings when tissue was centrally reviewed differed somewhat from those when tissue was reviewed loca...
News
- Author:
- Susan London
Publish date: June 11, 2018
CHICAGO – These findings mark the first major advance for this rare cancer in 30 years and have led to a new standard of care in Europe.
